166 related articles for article (PubMed ID: 28592888)
1. TCRα rearrangements identify a subgroup of NKL-deregulated adult T-ALLs associated with favorable outcome.
Villarese P; Lours C; Trinquand A; Le Noir S; Belhocine M; Lhermitte L; Cieslak A; Tesio M; Petit A; LeLorch M; Spicuglia S; Ifrah N; Dombret H; Langerak AW; Boissel N; Macintyre E; Asnafi V
Leukemia; 2018 Jan; 32(1):61-71. PubMed ID: 28592888
[TBL] [Abstract][Full Text] [Related]
2. CALM-AF10 is a common fusion transcript in T-ALL and is specific to the TCRgammadelta lineage.
Asnafi V; Radford-Weiss I; Dastugue N; Bayle C; Leboeuf D; Charrin C; Garand R; Lafage-Pochitaloff M; Delabesse E; Buzyn A; Troussard X; Macintyre E
Blood; 2003 Aug; 102(3):1000-6. PubMed ID: 12676784
[TBL] [Abstract][Full Text] [Related]
3. Analysis of TCR, pT alpha, and RAG-1 in T-acute lymphoblastic leukemias improves understanding of early human T-lymphoid lineage commitment.
Asnafi V; Beldjord K; Boulanger E; Comba B; Le Tutour P; Estienne MH; Davi F; Landman-Parker J; Quartier P; Buzyn A; Delabesse E; Valensi F; Macintyre E
Blood; 2003 Apr; 101(7):2693-703. PubMed ID: 12446444
[TBL] [Abstract][Full Text] [Related]
4. TLX homeodomain oncogenes mediate T cell maturation arrest in T-ALL via interaction with ETS1 and suppression of TCRα gene expression.
Dadi S; Le Noir S; Payet-Bornet D; Lhermitte L; Zacarias-Cabeza J; Bergeron J; Villarèse P; Vachez E; Dik WA; Millien C; Radford I; Verhoeyen E; Cosset FL; Petit A; Ifrah N; Dombret H; Hermine O; Spicuglia S; Langerak AW; Macintyre EA; Nadel B; Ferrier P; Asnafi V
Cancer Cell; 2012 Apr; 21(4):563-76. PubMed ID: 22516263
[TBL] [Abstract][Full Text] [Related]
5. IgH DJ rearrangements within T-ALL correlate with cCD79a expression, an immature/TCRgammadelta phenotype and absence of IL7Ralpha/CD127 expression.
Asnafi V; Beldjord K; Garand R; Millien C; Bahloul M; LeTutour P; Douay L; Valensi F; Macintyre E
Leukemia; 2004 Dec; 18(12):1997-2001. PubMed ID: 15483677
[TBL] [Abstract][Full Text] [Related]
6. Extensive molecular mapping of TCRα/δ- and TCRβ-involved chromosomal translocations reveals distinct mechanisms of oncogene activation in T-ALL.
Le Noir S; Ben Abdelali R; Lelorch M; Bergeron J; Sungalee S; Payet-Bornet D; Villarèse P; Petit A; Callens C; Lhermitte L; Baranger L; Radford-Weiss I; Grégoire MJ; Dombret H; Ifrah N; Spicuglia S; Romana S; Soulier J; Nadel B; Macintyre E; Asnafi V
Blood; 2012 Oct; 120(16):3298-309. PubMed ID: 22948044
[TBL] [Abstract][Full Text] [Related]
7. NKL homeobox gene activities in B-cell development and lymphomas.
Nagel S; MacLeod RAF; Meyer C; Kaufmann M; Drexler HG
PLoS One; 2018; 13(10):e0205537. PubMed ID: 30308041
[TBL] [Abstract][Full Text] [Related]
8. Aberrant activity of NKL homeobox gene NKX3-2 in a T-ALL subset.
Nagel S; Meyer C; Kaufmann M; Zaborski M; MacLeod RAF; Drexler HG
PLoS One; 2018; 13(5):e0197194. PubMed ID: 29746601
[TBL] [Abstract][Full Text] [Related]
9. NKL homeobox gene activities in hematopoietic stem cells, T-cell development and T-cell leukemia.
Nagel S; Pommerenke C; Scherr M; Meyer C; Kaufmann M; Battmer K; MacLeod RA; Drexler HG
PLoS One; 2017; 12(2):e0171164. PubMed ID: 28151996
[TBL] [Abstract][Full Text] [Related]
10. NK-like homeodomain proteins activate NOTCH3-signaling in leukemic T-cells.
Nagel S; Venturini L; Przybylski GK; Grabarczyk P; Meyer C; Kaufmann M; Battmer K; Schmidt CA; Drexler HG; Scherr M; Macleod RA
BMC Cancer; 2009 Oct; 9():371. PubMed ID: 19835636
[TBL] [Abstract][Full Text] [Related]
11. T cell receptor genotyping and HOXA/TLX1 expression define three T lymphoblastic lymphoma subsets which might affect clinical outcome.
Baleydier F; Decouvelaere AV; Bergeron J; Gaulard P; Canioni D; Bertrand Y; Lepretre S; Petit B; Dombret H; Beldjord K; Molina T; Asnafi V; Macintyre E
Clin Cancer Res; 2008 Feb; 14(3):692-700. PubMed ID: 18245528
[TBL] [Abstract][Full Text] [Related]
12. T cell receptor alpha-, beta-, and gamma-genes in T cell and pre-B cell acute lymphoblastic leukemia.
Felix CA; Wright JJ; Poplack DG; Reaman GH; Cole D; Goldman P; Korsmeyer SJ
J Clin Invest; 1987 Aug; 80(2):545-56. PubMed ID: 3497178
[TBL] [Abstract][Full Text] [Related]
13. Prognostic and oncogenic relevance of TLX1/HOX11 expression level in T-ALLs.
Bergeron J; Clappier E; Radford I; Buzyn A; Millien C; Soler G; Ballerini P; Thomas X; Soulier J; Dombret H; Macintyre EA; Asnafi V
Blood; 2007 Oct; 110(7):2324-30. PubMed ID: 17609427
[TBL] [Abstract][Full Text] [Related]
14. Early TCRalpha expression generates TCRalphagamma complexes that signal the DN-to-DP transition and impair development.
Erman B; Feigenbaum L; Coligan JE; Singer A
Nat Immunol; 2002 Jun; 3(6):564-9. PubMed ID: 12021779
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-3 receptor α chain (CD123) is preferentially expressed in immature T-ALL and may not associate with outcomes of chemotherapy.
Du W; Li J; Liu W; He Y; Yao J; Liu Y; Lin J; Zheng J
Tumour Biol; 2016 Mar; 37(3):3817-21. PubMed ID: 26474588
[TBL] [Abstract][Full Text] [Related]
16. Expression of human recombination activating genes (RAG1 and RAG2) in neoplastic lymphoid cells: correlation with cell differentiation and antigen receptor expression.
Bories JC; Cayuela JM; Loiseau P; Sigaux F
Blood; 1991 Oct; 78(8):2053-61. PubMed ID: 1832998
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of molecular-cytogenetic abnormalities in pediatric T-ALL is not explained by immunophenotypic differences.
van Grotel M; Meijerink JP; van Wering ER; Langerak AW; Beverloo HB; Buijs-Gladdines JG; Burger NB; Passier M; van Lieshout EM; Kamps WA; Veerman AJ; van Noesel MM; Pieters R
Leukemia; 2008 Jan; 22(1):124-31. PubMed ID: 17928886
[TBL] [Abstract][Full Text] [Related]
18. Clinical, cytogenetic and molecular characteristics of 14 T-ALL patients carrying the TCRbeta-HOXA rearrangement: a study of the Groupe Francophone de Cytogénétique Hématologique.
Cauwelier B; Cavé H; Gervais C; Lessard M; Barin C; Perot C; Van den Akker J; Mugneret F; Charrin C; Pagès MP; Grégoire MJ; Jonveaux P; Lafage-Pochitaloff M; Mozzicconacci MJ; Terré C; Luquet I; Cornillet-Lefebvre P; Laurence B; Plessis G; Lefebvre C; Leroux D; Antoine-Poirel H; Graux C; Mauvieux L; Heimann P; Chalas C; Clappier E; Verhasselt B; Benoit Y; Moerloose BD; Poppe B; Van Roy N; Keersmaecker KD; Cools J; Sigaux F; Soulier J; Hagemeijer A; Paepe AD; Dastugue N; Berger R; Speleman F
Leukemia; 2007 Jan; 21(1):121-8. PubMed ID: 17039236
[TBL] [Abstract][Full Text] [Related]
19. Murine Pten(-/-) T-ALL requires non-redundant PI3K/mTOR and DLL4/Notch1 signals for maintenance and γc/TCR signals for thymic exit.
Hagenbeek TJ; Wu X; Choy L; Sanchez-Irizarry C; Seshagiri S; Stinson J; Siebel CW; Spits H
Cancer Lett; 2014 May; 346(2):237-48. PubMed ID: 24384093
[TBL] [Abstract][Full Text] [Related]
20. Use of oligonucleotide probes directed against T cell antigen receptor gamma delta variable-(diversity)-joining junctional sequences as a general method for detecting minimal residual disease in acute lymphoblastic leukemias.
Macintyre EA; d'Auriol L; Duparc N; Leverger G; Galibert F; Sigaux F
J Clin Invest; 1990 Dec; 86(6):2125-35. PubMed ID: 2174915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
